Apply to NIH FIRST at Mount Sinai

The NIH FIRST at Mount Sinai program aims to transform culture by building a self-reinforcing community of scientists committed to inclusive excellence. To accomplish this goal, we are recruiting a diverse group of faculty for research tenure-track or equivalent faculty positions (Assistant Professor or equivalent level). Candidates must not have held a position at this level, and must also be able to demonstrate a strong commitment to promoting diversity and inclusive excellence.

Launching a comprehensive program to promote and sustain an academic culture of inclusive excellence

The Friedman Brain Institute

The Friedman Brain Institute is world-renowned for advancing our understanding of brain and nervous system disorders. Our researchers are pioneering innovative approaches to treatment and diagnostics through translational research.

The Institute for Health Equity Research

The Institute for Health Equity Research brings together a multidisciplinary team to address the disparities in health and health care that have had long-standing roots in our country. Our team conducts groundbreaking research to engage at-risk communities, enable access to life-changing resources, and inform life-saving interventions.

The Tisch Cancer Institute

The Tisch Cancer Institute is a National Cancer Institute-designated cancer center, known throughout the world for landmark cancer research and treatment. The mission of The Tisch Cancer Institute is to advance basic, clinical, and population health cancer research in order to help prevent and eradicate cancer. Our clinical breakthroughs have improved and saved the lives of our patients, their families, and the diverse communities we serve.

The Global Health and Emerging Pathogens Institute

The Global Health and Emerging Pathogens Institute is the nucleus of the Icahn School of Medicine at Mount Sinai’s work on infectious diseases and the pathogens that cause them. The Institute is recognized internationally for its expertise in RNA virus research and ongoing research on the molecular pathogenesis and host responses of influenza, HIV, Dengue, Zika, Ebola, and other emerging and re-emerging virus infections.